January 27, 2023Open Access

Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our data highlight a context-specific ferroptosis-induced immune response that could be therapeutically exploited for the treatment of primary liver tumours and liver metastases.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Conche et al. (Fri,) studied this question.

synapsesocial.com/papers/69d7f1c95c3030ff03d1881b https://doi.org/https://doi.org/10.1136/gutjnl-2022-327909

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape2017 · 42 citations
2Immunogenic cell death in cancer and infectious disease2016 · 3,002 citations
3Transferrin Receptor Is a Specific Ferroptosis Marker2020 · 889 citations
4Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer2018 · 4 citations
5A Preclinical Murine Model of Hepatic Metastases2014 · 118 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo